These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2834018)

  • 1. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.
    Krahn DD; Gosnell BA; Levine AS; Morley JE
    Brain Res; 1988 Mar; 443(1-2):63-9. PubMed ID: 2834018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats.
    Mönnikes H; Heymann-Mönnikes I; Taché Y
    Brain Res; 1992 Mar; 574(1-2):70-6. PubMed ID: 1638411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H; Shibasaki T
    Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
    Brown MR; Hauger R; Fisher LA
    Brain Res; 1988 Feb; 441(1-2):33-40. PubMed ID: 2834002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.
    Vergoni AV; Bertolini A; Wikberg JE; Schiöth HB
    Peptides; 1999; 20(4):509-13. PubMed ID: 10458522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
    Saunders WS; Thornhill JA
    Peptides; 1986; 7(4):597-601. PubMed ID: 3020526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats.
    Arase K; Shargill NS; Bray GA
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R751-6. PubMed ID: 2784291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.
    Britton DR; Koob GF; Rivier J; Vale W
    Life Sci; 1982 Jul; 31(4):363-7. PubMed ID: 6983018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF-induced excessive grooming behavior in rats and mice.
    Dunn AJ; Berridge CW; Lai YI; Yachabach TL
    Peptides; 1987; 8(5):841-4. PubMed ID: 3501576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both conditioned taste preference and aversion induced by corticotropin-releasing factor.
    Heinrichs SC; Britton KT; Koob GF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):717-21. PubMed ID: 1667823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats.
    Arase K; York DA; Shimizu H; Shargill N; Bray GA
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E255-9. PubMed ID: 3262311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.
    Benoit SC; Thiele TE; Heinrichs SC; Rushing PA; Blake KA; Steeley RJ
    Peptides; 2000 Mar; 21(3):345-51. PubMed ID: 10793215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies.
    Matsuzaki I; Takamatsu Y; Moroji T
    Neuropeptides; 1989 Apr; 13(3):147-55. PubMed ID: 2785246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
    Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
    J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.
    Dagnault A; Ouerghi D; Richard D
    Brain Res Bull; 1993; 32(6):689-92. PubMed ID: 8221168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.